【新闻稿】近日，国内生物科技领域传来喜讯，专注于AI蛋白质设计与优化的创新型公司——「途深智合」成功获得诚美资本的数百万元天使轮融资。这一轮融资不仅彰显了资本市场对人工智能在生物科技应用前景的认可，也为「途深智合」的未来发展注入了强劲动力。
「途深智合」成立于2023年，这家年轻而富有创新精神的企业，致力于运用人工智能技术进行蛋白质设计和制造，为合成生物学领域提供前沿的解决方案和创新产品。本次融资的资金将主要用于实验室的建设和专业团队的扩充，以提升公司在蛋白质工程领域的研发能力和技术水平。
「途深智合」的创始人表示，公司将借助这笔资金，进一步加速在AI蛋白质设计领域的技术研发，打造更加高效、精准的生物合成工具，以满足日益增长的市场需求。诚美资本的投资，不仅为「途深智合」提供了资金支持，更带来了丰富的行业资源和战略指导，将有力推动公司的快速成长。
此轮融资的成功，标志着「途深智合」在人工智能与生物科技交叉领域的探索迈出了坚实的步伐。未来，「途深智合」将如何运用AI技术改写蛋白质工程的篇章，我们拭目以待。
英语如下：
News Title: “AI Empowers Biotech, ‘Tushen Zhike’ Secures Million-Dollar Angel Round for Protein Design Revolution”
Keywords: AI Protein Design, Tushen Zhike, Angel Round Investment
Press Release: Recently, a piece of delightful news emerged in China’s biotech sector: ‘Tushen Zhike,’ an innovative company specializing in AI-driven protein design and optimization, has successfully secured millions of dollars in an angel funding round led by Chengmei Capital. This investment not only demonstrates the capital market’s recognition of AI’s potential in biotechnology applications but also injects strong momentum into ‘Tushen Zhike’s’ future development.
Founded in 2023, the young and innovative company focuses on using AI technology for protein design and manufacturing, offering cutting-edge solutions and innovative products to the synthetic biology field. The funds raised will primarily be allocated to laboratory expansion and the augmentation of the professional team, enhancing the company’s R&D capabilities and technological expertise in protein engineering.
The founder of ‘Tushen Zhike’ stated that the company will leverage the funds to accelerate AI-driven protein design research, developing more efficient and precise biological synthesis tools to cater to the growing market demand. Chengmei Capital’s investment not only provides financial backing but also brings valuable industry resources and strategic guidance, propelling the company’s rapid growth.
This successful funding round signifies a robust step forward in ‘Tushen Zhike’s’ exploration at the intersection of AI and biotechnology. As we look forward, it remains to be seen how ‘Tushen Zhike’ will utilize AI technology to rewrite the narrative of protein engineering.
【来源】https://36kr.com/p/2686282258132355
Views: 1